Senior Cost Accountant
Eva Pharma
- Employment
- Full-time
- Seniority
- Senior
About the role
Company Overview
Join EVA Pharma, a leading pharmaceutical company dedicated to empowering the fight for Health and well-being as a fundamental human right. Recognized and certified as a best place to work, we are committed to fostering a supportive and innovative environment for our team members.
Job Summary
We are seeking a passionate and talented Cost Accountant to join our dynamic team. The ideal candidate will contribute to our mission of enhancing human health and well-being, ensuring that we meet the highest standards of excellence in our industry.
Key Responsibilities
- Prepare and analyze cost reports related to manufacturing processes, ensuring accurate tracking of costs and expenses.
- Conduct product cost analysis, including bill of materials, labor costs, and overhead rates to support pricing decisions.
- Monitor and manage inventory levels, conducting regular audits to ensure accuracy in valuation.
- Assist in budgeting and forecasting processes by providing insights on cost trends and variances.
- Collaborate with cross-functional teams to identify areas for cost reduction and process improvement.
- Ensure compliance with financial regulations and internal controls while maintaining accurate financial records.
Requirements
- Bachelor’s degree in Accounting, Finance, or a related field.
- 3-5 years of experience in cost accounting or financial analysis, preferably in the manufacturing or pharmaceutical industry.
- Proficiency in accounting software and ERP systems; experience with Oracle is a plus.
- Fluency in English is required.
753,000+ hidden jobs like this
Eva Pharma and thousands of companies post here first — often days before LinkedIn or Indeed. Your first 5 applications are free; go Pro to apply without limits.
Everything Pro unlocks:
- Unlimited applications — free stops at 5
- Track every application in one place
- Apply straight to the source, one click
- Save & organize roles you love
- Roles pulled from company boards before the big sites